T reatment of chronic total occlusions (CTO) using percutaneous coronary interventions (PCI) is a topic that has received considerable interest. CTOs have received this attention because they are prevalent among patients with coronary artery disease [1] [2] [3] [4] [5] and are present in as many as 10% to 20% of all patients referred for diagnostic angiography. 6, 7 However, PCI success rates for CTO have been demonstrated in earlier studies to be only in the 60% to 70% range, 8 although some centers have reported success rates >80%.
procedure choices, provider identifiers, discharge status, and in-hospital adverse outcomes. There is lesion-specific information in the registry that includes the location of the lesion, whether it had been bypassed, whether it was attempted, the pre-and postprocedural stenosis, the devices and types of stents used, and various complex lesion characteristics. CTO is a data element in the registry, and CTOs are defined as lesions with preprocedure stenosis of 100% presumed to be 100% occluded for at least 3 months before the procedure, regardless of whether there is any documentation of the time frame. The treatment indication was symptomatic myocardial ischemia and evidence of reversible myocardial ischemia by perfusion imaging or stress testing.
Completeness of data reporting is monitored by matching PCIRS to New York's acute care hospital discharge database, the Statewide Planning and Research Cooperative System (SPARCS), and to the Department of Health's Ambulatory Surgery Database. SPARCS contains patient demographics (age, sex, and race), diagnoses and procedures, admission and discharge dates, and discharge disposition for all patients discharged from nonfederal acute care hospitals in New York. PCIRS records were matched with SPARCS records using unique hospital identifiers along with patient identifiers and admission, surgery, and discharge dates. Inhospital outcomes are matched to SPARCS to ensure accuracy, and the Department of Health's utilization review agent audits samples of records from hospitals to ensure the accuracy of risk factor reporting. PCIRS was also matched to New York's vital statistics database to identify deaths that occur after discharge for New York State patients.
Patients and Hospitals
A total of 156 043 US patients underwent PCI in New York between July 1, 2009 , and June 30, 2012. We excluded patients who have had shock or anoxic brain injury (625), myocardial infarction (MI) within 24 hours before the index procedure (22 646) , and patients in the one hospital not reporting CTO data (1799), leaving a total of 130 973 patients, 4030 of whom underwent a CTO PCI. The number of hospitals in which these patients underwent revascularization during this time period was 61. For subsequent analyses of longer-term mortality among the patients who underwent CTO PCI, patients were excluded if they were from out-of-state (378), if they did not have a valid social security number (189), or if they had a second admission with a CTO PCI in the study period (252). This left a total of 3211 patients with CTO PCIs for the 2.5-year mortality analyses.
Statistical Analysis
The percentage of PCI patients with CTO PCIs was calculated, and the variation in this percentage across hospitals was examined. Demographic and clinical characteristics of CTO PCI patients and non-CTO patients were compared. The success rate for CTO PCI was calculated, and patient characteristics were compared for patients with a successful CTO PCI and patients with an unsuccessful CTO PCI. Also, inter-hospital differences in success rates were examined. Angiographic success was defined as a residual stenosis of <50% in all attempted CTO lesions. Complications were not included in the success measure because many patients had another lesion attempted, and it was impossible to tell which lesion was related to the complication. However, we did compare complication rates for patients with only a CTO PCI to patients with only a non-CTO PCI.
For comparisons of patient characteristics in the above analyses, Chi-square tests were used for binary variables, Cochran-Armitage tests were used for ordinal categorical variables, and the t test was used to test for differences in means.
A hierarchical multivariable logistic regression model using PROC GLIMMIX in SAS 9.2 was used to evaluate independent correlates of successful CTO PCI among patients undergoing CTO PCIs. The first level of the model consisted of patient-related risk factors available in the registry. The second level of clustering was at the operator level, and the variables used were operator volume quartiles. The purposes of the model were to identify significant patient-level correlates of successful CTO PCI (versus unsuccessful CTO PCI) and to determine if operator volume is associated with successful CTO PCI after controlling for patient-level correlates.
After adjusting for differences in the prevalence of patient risk factors, 2.5-year mortality (with a mean follow-up of 1.8 years) was compared for patients with successful and unsuccessful CTO PCIs. The mortality rates were risk-adjusted using a stepwise Cox proportional hazards model, with all patient risk factors in the registry used as candidates for control variables. The primary study variable was a categorical variable whose categories represented a combination of success for CTO lesions and overall completeness of revascularization for other lesions. Completeness of revascularization for all other lesions was defined as a residual stenosis of <50% for all lesions with preprocedural stenoses of at least 70%. The reference category for the variable was successful CTO PCI and CR of all other lesions with preprocedural stenosis of at least 70%. Also, if a CTO or non-CTO PCI was successful in a staged admission, that patient was regarded as having undergone a successful PCI. In addition, incomplete revascularization (IR) was examined in conjunction with lesions treated because of numerous studies that show superior outcomes with CR.
All tests were 2-sided and conducted at the 0.05 level, and all analyses were conducted in SAS 9.2 (SAS Institute, Cary, NC).
Results
A total of 4030 (3.1%) PCI patients in the study underwent CTO PCI. The hospital volumes of CTO PCIs ranged from 0 to 1118, and the percentage of PCIs that were CTO PCIs ranged from 0% to 7.91% across hospitals. Table 1 compares patient characteristics for patients undergoing PCI for CTO (or CTO with ≥1 other lesions) with patients undergoing non-CTO PCI. Patients with CTO PCIs were younger, more likely to be male, less likely to be white, who had lower ejection fractions, more likely to have had a
WHAT IS KNOWN
• PCI for CTO has been identified as a beneficial treatment, but little is known about its use in everyday practice, and little is known about its volume-outcome relationship and the relative outcome of successful versus failed CTO PCI when adjusting for completeness of revascularization of CTO and other lesions.
WHAT THE STUDY ADDS
• In New York State, the success rate for CTO PCI in 2009-2012 was 61%, far lower than that for other lesions.
• CTO PCI operator volume was highly associated with successful CTO PCI, with operators performing >48 per year having success rates twice as high as the lower half of operators who performed <9 per year.
• Patients with unsuccessful CTO PCIs had significantly higher 2.5-year mortality (adjusted hazard ratio [AHR], 1.63; 95% confidence interval [CI], 1.28-2.08]) than patients who had complete revascularization for all CTO and other diseased lesions.
previous MI and previous PCI, less likely to have carotid/cerebrovascular disease, chronic obstructive pulmonary disease, renal failure, and left main disease, and more likely to have multivessel disease.
The in-hospital complication rate for patients with only CTO PCIs was 1.06% (25/2358), and the rate for patients with only non-CTO PCIs was 1.07% (1364/126 943). There was no significant difference in the rates (P=0. 95). The overall success rate for CTO PCIs was 61.3%. Success rates for hospitals with at least 5 CTO PCIs ranged from 10% to 80%, with a median of 56% (see Figure 1) . The median success rate for individual operators with at least 5 CTO PCIs for the 3-year period was 60%, ranging from 0% to 100%. See Figure 2 for a frequency distribution. Table 2 compares patients with failed CTO PCI and patients with a successful CTO PCI. Patients with a successful PCI were younger, more likely to be Asian, and less likely to be black; who had higher ejection fractions; with fewer previous MIs, PCIs, and coronary artery bypass grafting surgery; less likely to have carotid/cerebrovascular disease; and more likely to have had a PCI with another lesion attempted in addition to the CTO. Also, on average, they had operators with Table 3 presents the results of a hierarchical multivariable logistic regression model that contains significant unadjusted correlates of success in the univariable analysis as independent variables and success (all attempted lesions had <50% residual stenosis) as the dependent variable. As indicated, significant independent correlates of lack of success with CTO PCIs include older age, ejection fractions <20%, previous PCIs and coronary artery bypass grafting surgery, carotid/cerebrovascular disease, PCIs that only involve CTOs, right coronary artery and left circumflex CTO lesion locations, and lower operator CTO PCI volume in the previous year. Operators performing ≤3 CTO PCIs per year had odds that were only 41% as high of achieving success as operators with ≥48 CTO PCIs per year (adjusted odds ratio [AOR], 0.41; 95% CI, 0.24-0.69), and operators with 4 to 8 CTO PCIs per year had odds that were only half as high of achieving success as the group with ≥48 per year (AOR, 0.50; 95% CI, 0.29-0.85). The interclass correlation coefficient for the model was 0.08, indicating that 8% of the variation in CTO success was accounted for by operator CTO volumes. Table 4 presents the results of the statistical model that examines 2.5-year mortality for CTO PCI patients as a function of the completeness of revascularization of CTO and other lesions while adjusting for numerous patient risk factors. The study variable was a categorical variable whose categories were CR of all diseased lesions (the reference category), CR of CTO lesions and IR of ≥1 other lesions, and IR of CTO lesions. As noted in Table 4 , numerous control variables (age, race other than Asian, low ejection fractions, previous MI, and several comorbidities) were significant correlates of mortality. Patients with CR of their CTO lesions (meaning all attempted successfully) but IR of ≥1 other lesions did not have a significantly higher mortality than patients who had all lesions completely revascularized (AHR, 1.11; 95% CI, 0.74-1.68). However, patients with incompletely revascularized CTO lesions, regardless of the completeness of other lesions, had higher mortality (AHR, 1.63; 95% CI, 1.28-2.08) than patients with all diseased lesions completely revascularized. Also, we found that in comparison to patients undergoing non-CTO PCI, patients with CTO PCIs were younger, more likely to be male, less likely to be white, and sicker in many respects (eg, they had lower ejection fractions, were more likely to have had a previous MI and previous PCI, and were more likely to have multivessel disease). However, they were less likely to have carotid/cerebrovascular disease, chronic obstructive pulmonary disease, renal failure, and left main disease.
The overall success rate for CTO PCIs was 61.3%. Individual hospital success rates for CTO PCIs ranged from 10% to 80% with a median hospital success rate of 56% for hospitals with at least 5 CTO PCIs in the 3-year period. The median success rate for individual operators with at least 5 CTO PCIs was 60%.
Also, in comparison to patients with failed CTO PCI, patients with a successful PCI tended to be healthier. They were younger, had higher ejection fractions, had fewer previous PCIs and coronary artery bypass grafting surgery, and had less likelihood of having carotid/cerebrovascular disease. In addition, they were more likely to have the CTO in the left anterior descending artery and were more likely to have had a PCI with another lesion attempted in addition to the CTO. Importantly, they had operators with higher annual CTO PCI volumes, and the operators who performed ≥48 CTO PCIs per year-the highest quartile-were more than twice as likely to achieve success as operators performing an average of ≤8 per year-the lowest half in volume. Thus, the heterogeneity of operator CTO volume combined with the fact that only one quarter of operators performed ≥48 CTO PCIs is an extremely important correlate of success, and 20% of all of the variation in success rates was accounted for by this variation.
Many of these findings are similar to the findings of Brilakis et al 12 in a recent study they conducted using data from the National Cardiovascular Data Registry (NCDR). In contrast to our 3.1%, they found 3.8% of PCI patients undergoing CTO PCI. Furthermore, they found a nearly identical success rate (59%) as the 61% in the New York registry. They also found some patient risk characteristics in common with our study that were associated with lack of CTO procedural success, including age, previous coronary artery bypass grafting surgery, right coronary artery CTO target vessel (in contrast to the left anterior descending artery), and low operator experience. However, some of the factors we found associated with failure (higher ejection fractions, previous PCI, carotid/cerebrovascular disease, CTO PCIs with ≥1 PCIs in other lesions) were not identified as contributing to CTO failure. Although the Brilakis study is larger than ours, a strength of our study in relation to the Brilakis study is that we were able to obtain 2.5-year outcomes for patients as a function of the success of their CTO PCI and the completeness of their revascularization. Also, our study is virtually population-based in that it includes all CTO PCIs in nonfederal hospitals in New York.
Other recent studies have also found superior results in patients with successful CTO PCI compared with patients with failed CTO PCI. For example, in a meta-analysis conducted by Hoebers et al, the authors found that successful recanalization of a CTO resulted in an overall improvement of 4.44% absolute left ventricular ejection fraction points and improved survival (odds ratio [OR], 0.52; 95% CI, 0.43-0.62) compared with failed CTO.
14 Also, Galassi et al found that a retrograde approach improves the success rate of PCI CTOs, with procedural and clinical success rates of 75.3% and 71.2%, respectively. 15 With regard to longer-term outcomes, our study found that patients with incompletely revascularized (unsuccessful) CTO lesions had significantly higher mortality (AHR=1.63 (1.28, 2.08)) than patients who had CR for all CTO and other diseased lesions. These findings are similar to those of other recent studies. For example, Joyal et al conducted a meta-analysis of 13 observational studies encompassing 7288 patients that compared outcomes after successful versus failed CTO for a weighted average follow-up of 6 years. 16 Findings of the study were that the mortality rate for patients with successful CTO was significantly lower than the rate for patients with failed CTO (14.3% versus 17.5%, OR, 0.56; 95% CI, 0.43-0.72). There was also a significant reduction in subsequent coronary bypass graft surgery (OR, 0.22; 95% CI, 0.17-0.27), but not for MI or major adverse cardiac events.
Also, George et al used data from the UK Central Cardiac Audit Database between 2005 and 2009 to follow patients with successful and failed CTO PCI for a median of 2.65 years. 17 The authors found that successful PCI of at least one CTO was associated with improved survival (hazard ratio [HR], 0.72; 95% CI, 0.62-0.83). Also, CR was associated with improved survival compared with partial revascularization (HR, 0.70; 95% CI, 0.56-0.87) or failed revascularization (HR, 0.61; 95% CI, 0.50-0.74).
An advantage of our study in comparison with the Joyal and George studies is that we were able to examine success of CTO PCIs more broadly by defining procedures that were successfully staged at a later date as a success. Also, we examined the impact of CR of non-CTO lesions on 2.5-year outcomes because of numerous studies that have shown the benefits of CR for PCI. [18] [19] [20] [21] [22] We found that unsuccessful revascularization of the CTO lesion was associated with lower survival than the reference (successful CTO revascularization accompanied by CR of all other diseased lesions). Furthermore, although there was an increased risk for patients with successful CTO revascularization in conjunction with IR of other diseased lesions in comparison to patients who received CR of all disease lesions, the difference was not significant. Thus, in conclusion, complete (successful) revascularization of CTOs is associated with improved 2.5-year mortality even after adjusting for other factors that are associated with mortality.
Limitations of our study include the fact that it is limited to New York State, and so the findings may not be representative of the entire United States. Also, we were unable to assess the extent of collateral circulation that existed in CTO vessels, whether the CTO was serving infarcted myocardium, or the strategies used in CTO PCIs. We also do not know the decision-making process for undertaking CTO PCIs, and therefore, confounding variables may have contributed to at least some of the variation across hospitals in choosing to perform CTO PCIs as well as the variation in success rates for CTO PCI.
Another limitation is that we did not have access to all variables required to assess the baseline and residual Synergy Between PCI With Taxus and Cardiac Surgery (SYNTAX) scores. This information would have enabled us to fine tune our adjustment for completeness of revascularization when examining the impact of PCI treatment of CTOs in patients with multivessel disease by adjusting for reasonable IR. 23 In addition, we did not have information on the existence of CTOs in patients undergoing PCI on other diseased lesions but not CTO PCI or on patients with CTOs as the only diseased lesion who did not undergo PCI. This is unfortunate because a study of CTO that were treated versus not treated by PCI would have been especially informative.
In conclusion, CTO PCIs comprise a low percentage of all PCIs, and their success rate is low in comparison to PCI for non-CTO lesions. For CTOs that operators attempt to open, unsuccessful attempts are associated with significantly higher 2.5-year mortality than for successful attempts. Also, operators who perform more CTO PCIs have higher success rates.
